Back to companies
Intellia Therapeutics, Inc.
NTLAUSNASDAQPharmaceuticals & HealthcareIntellia Therapeutics, Inc.
Revenue
$67.7mn
YoY +16.9%
Operating income
-$441.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API